A new study sponsored from Shockwave Medical, which specializes in coronary intravascular lithotripsy (IVL), is designed to close the deadly gender gap in coronary artery disease (CAD).
Shockwave Begins First All-Female Study Of Coronary Interventions
The EMPOWER CAD trial will evaluate Shockwave’s intravascular lithotripsy system in female patients undergoing a percutaneous coronary intervention for coronary artery disease. Principal investigator Alexandra Lansky spoke to Medtech Insight about the first-of-its kind study in this understudied population.
